Virtus Biotech ETF (BBP)

Assets	$54.87M
Expense Ratio	0.34%
PE Ratio	n/a
Shares Out	650,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	2,820
Open	84.83
Previous Close	85.82
Day's Range	84.12 - 84.83
52-Week Low	50.37
52-Week High	87.17
Beta	0.61
Holdings	64
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

26.64% of assets

Name	Symbol	Weight
ImmunityBio, Inc.	IBRX	4.79%
Day One Biopharmaceuticals, Inc.	DAWN	3.88%
Iovance Biotherapeutics, Inc.	IOVA	2.76%
Moderna, Inc.	MRNA	2.63%
Apellis Pharmaceuticals, Inc.	APLS	2.44%
Mirum Pharmaceuticals, Inc.	MIRM	2.30%
BioCryst Pharmaceuticals, Inc.	BCRX	1.97%
Novavax, Inc.	NVAX	1.96%
Geron Corporation	GERN	1.96%
Roivant Sciences Ltd.	ROIV	1.95%

Performance

BBP had a total return of 59.00% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.95%.